Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SBBP

Strongbridge Biopharma (SBBP) Stock Price, News & Analysis

Strongbridge Biopharma logo

About Strongbridge Biopharma Stock (NASDAQ:SBBP)

Key Stats

Today's Range
$1.95
$2.06
50-Day Range
$1.89
$2.29
52-Week Range
$1.85
$4.26
Volume
684,684 shs
Average Volume
866,464 shs
Market Capitalization
$135.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA.

Receive SBBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Strongbridge Biopharma and its competitors with MarketBeat's FREE daily newsletter.

SBBP Stock News Headlines

Matinas BioPharma Holdings Inc (MTNB)
Lytix Biopharma As Share Price (LYTIX.OL)
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
Ambrx Biopharma Inc AMAM
HILS Hillstream BioPharma, Inc.
ABUS - Arbutus Biopharma Corporation
See More Headlines

SBBP Stock Analysis - Frequently Asked Questions

Strongbridge Biopharma plc (NASDAQ:SBBP) issued its quarterly earnings data on Thursday, August, 5th. The biotechnology company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.09. The biotechnology company earned $10.04 million during the quarter, compared to the consensus estimate of $8.83 million. Strongbridge Biopharma had a negative net margin of 115.67% and a negative trailing twelve-month return on equity of 66.82%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Strongbridge Biopharma investors own include Energy Transfer (ET), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), OPKO Health (OPK) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/05/2021
Today
11/02/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SBBP
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

Net Income
$-45,080,000.00
Net Margins
-115.67%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$30.73 million
Book Value
$0.98 per share

Miscellaneous

Free Float
N/A
Market Cap
$135.66 million
Optionable
Optionable
Beta
1.58

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:SBBP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners